Safety and efficacy of first-line nivolumab (NIVO) and ipilimumab (IPI) in non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Hellmann, M. D.; Rizvi, N.; Gettinger, S. N.; Goldman, J.; Chow, L. Q.; Juergens, R.; Borghaei, H.; Brahmer, J.; Shen, Y.; Harbison, C. T.; Nathan, F.; Ready, N. E.; Antonia, S. J. |
| Abstract Title: | Safety and efficacy of first-line nivolumab (NIVO) and ipilimumab (IPI) in non-small cell lung cancer (NSCLC) |
| Meeting Title: | 18th European Cancer Conference (ECCO 18) |
| Journal Title: | European Journal of Cancer |
| Volume: | 51 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2015 Sep 25-29 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S632 |
| End Page: | S633 |
| Language: | English |
| ACCESSION: | WOS:000361887403055 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(16)31738-5 |
| Notes: | Meeting Abstract: 3097 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
